PRA partnered with the sponsor’s new pediatric oncology department on an innovative pediatric oncology program. The program provided early evaluation of oncology treatments on children with relapsed or refractory solid tumors, fulfilling an unmet need in the industry.
The Need for More Elderly Patients in Cancer Clinical Trials
With fall in the air in the northern hemisphere, it’s also a week full of noteworthy news in clinical development. New research shines a light on…
Surviving isn't Thriving: FDA RACE for Children Act brings hope for curing childhood cancer
With difficulties in research for pediatric cancer treatments the FDA RACE for Children Act brings hope for curing childhood cancer, and saving the…